Search
for
Sort by
Research 30 of 1000+
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis
- How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?
- Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Clinical analysis of 78 patients with non-classical 21-hydroxylase deficiency
- Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone
- CYP21A2 Mutations in Women with Polycystic Ovary Syndrome (PCOS)
- Congenital Adrenal Hyperplasia
- Female Pseudohermaphroditism Caused by a Novel Homozygous Missense Mutation of the GR Gene
- Retrospective evaluation of sex hormones and steroid hormone intermediates in dogs with alopecia
- Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index
- The role of antimullerian hormone in the hormonal workup of women with persistent acne
- Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman
- Congenital Adrenal Hyperplasia
- Hormonal Parameters in Androgenetic Hair Loss in the Male
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- Androgens in women
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Clinico-investigative profile of patients of hirsutism in a tertiary level institution
- Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients
- Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome
- Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- Hirsutism – From Diagnosis to Use of Antiandrogens